Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 19, 2024

Efficacy of Everolimus Combined With Hormonal Treatment Following CDK4/6 Inhibitor Therapy

Breast Cancer Research and Treatment

 

Additional Info

Breast Cancer Research and Treatment
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
Breast Cancer Res Treat 2024 Dec 01;208(3)597-604, İ Beypınar, H Demir, Ş Yaslıkaya, T Köşeci, B Demir, G Çolak, AB Ağaoğlu, M Şahbazlar, PC Şancı, D Çabuk, U Işık, E Şahin, A Coşkun, B Caner, T Aykut, M Artaç, ME Duygulu, N Sever, S Öksüz, N Turan, MB Aykan, EK Tüzün, M Uysal, İ Uğurlu, A Sakin, C Acar, D Özaşkın, T Şakalar, M Keskinkılıç, T Yavuzşen, N Köse, İ Ertürk, N Yıldırım, OY Balçık, A Alkan, O Selvi, E Erçin, OÜ Ünal, C Karaçin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading